Among “extra-criteria” antiphospholipid (aPL) antibodies, anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies, are considered a part of risk assessment strategies when …

Abstract Background: Diagnosing Antiphospholipid Syndrome (APS) relies heavily on
laboratory findings, particularly the detection of specific antibodies like lupus anticoagulant …

Antiphospholipid syndrome (APS) is the most common acquired thrombophilia, an
autoimmune disorder characterized by arterial and/or venous thrombosis and/or pregnancy …

Phosphatidylserine-dependent antiprothrombin antibodies (aPS/PT) were strongly
correlated with the presence of lupus anticoagulant showing a high specificity for the …

Patients with antiphospholipid syndrome (APS) present with clinical features of recurrent
thrombosis and pregnancy morbidity and persistently test positive for the presence of …

Since the discovery that antiphospholipid antibodies (aPL) bind to a cofactor at the
phospholipid membrane, the proteins beta-2-glycoprotein I (β2GPI) and prothrombin …

Background Persistent antiphospholipid antibodies (aPL) constitute the serological hallmark
of the antiphospholipid syndrome (APS). Recently, various new assay technologies for the …

Purpose To evaluate the impact of the introduction of the anti-phosphatidylserine/
prothrombin autoantibodies (aPS/PT) in the laboratory diagnostic process of anti …

The place of non-criteria antiphospholipid antibodies (aPLs) in the diagnosis of
antiphospholipid syndrome (APS) is still debatable. The aim of this research was to evaluate …

Detection of anti-phospholipid (aPL) antibodies for state-of-the art diagnosis of
antiphospholipid syndrome (APS) still remains a laboratory challenge due to the great …